首页> 外文期刊>Leukemia Research Reports >Sezary syndrome manifesting as posttransplant lymphoproliferative disorder
【24h】

Sezary syndrome manifesting as posttransplant lymphoproliferative disorder

机译:Sezary综合征表现为移植后淋巴增生性疾病

获取原文
       

摘要

Posttransplant lymphoproliferative disorders (PTLDs) of T-cell orgin are rare biologically heterogeneous diseases of mature lymphoid cells manifesting in immunosuppressed patients. Only a few cases of mycosis fungoides diagnosed post allogeneic hematopoietic cell transplant (alloHSCT) have been described so far. We present a patient with myelodysplastic syndrome (MDS) post matched unrelated donor alloHSCT who was on long-term immunosuppressive therapy due to graft versus host disease. Three years after an alloHSCT, she developed generalized erythroderma and peripheral blood lymphocytosis. Both skin biopsy and peripheral blood flow cytometry revealed atypical CD4+ T-cell population consistent with diagnosis of Sezary syndrome. Chimerism studies revealed 100% donor engraftment. Therapy with extracorporeal photopheresis resulted in complete response in blood and skin.
机译:T细胞起源的移植后淋巴细胞增生性疾病(PTLD)是免疫抑制患者中罕见的成熟淋巴细胞生物学异质性疾病。迄今为止,仅描述了少数在异基因造血细胞移植(alloHSCT)后被诊断为真菌病的真菌病例。我们介绍了一名匹配不相关的供体alloHSCT后患有骨髓增生异常综合征(MDS)的患者,该患者由于移植物抗宿主疾病而接受长期免疫抑制治疗。进行异基因造血干细胞移植三年后,她发展为全身性红皮病和外周血淋巴细胞增多。皮肤活检和外周血流式细胞术均显示非典型的CD4 + T细胞群与Sezary综合征的诊断相符。嵌合体研究显示100%的供体植入。体外光透疗法的治疗导致血液和皮肤完全反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号